Oscar Health (OSCR) Revenue (2020 - 2026)

Oscar Health (OSCR) has reported Revenue for 7 consecutive years, with $4.9 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 70.4% year-over-year to $4.9 billion; the trailing twelve-month figure through Jun 2026 stood at $15.3 billion (up 42.82% YoY), and the FY2025 full-year result was $11.7 billion, up 27.5% from the prior year.
• Revenue improved to $4.9 billion in Q2 2026 per OSCR's latest filing, from $4.6 billion in the prior quarter.
• Across five years, Revenue topped out at $4.9 billion in Q2 2026 and bottomed at $972.8 million in Q1 2022.
• Historically, Revenue has averaged $2.2 billion across 5 years, with a median of $2.2 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Revenue soared 163.35% in 2022, then climbed 17.25% in 2025.
• Over 5 years, Revenue stood at $995.1 million in 2022, then soared by 43.87% to $1.4 billion in 2023, then surged by 67.11% to $2.4 billion in 2024, then rose by 17.25% to $2.8 billion in 2025, then soared by 73.97% to $4.9 billion in 2026.
• According to Business Quant data, Revenue over the past three periods registered $4.9 billion, $4.6 billion, and $2.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.